Max Robotics — Global Service Robot Directory + US Certification

About

Seth A. Strope is a leading urologic oncologist whose research centers on the diffusion of advanced surgical technologies in prostate and bladder cancer treatment, with a particular focus on patient-reported outcomes and the overuse of aggressive therapies. His most influential work, a 2013 study with 141 citations, critically examined the widespread adoption of intensity-modulated radiotherapy (IMRT) and robotic prostatectomy among men at low risk of dying from prostate cancer, raising essential questions about the balance between technological innovation and patient-centered care. Strope has also made foundational contributions to robotic surgery outcomes, including early oncologic results for robotic versus open radical cystectomy (51 citations) and a landmark single-surgeon series of 2,500 robotic-assisted radical prostatectomies, which applied standardized complication grading to demonstrate the safety of the approach. His investigation into surgeon variation in post-prostatectomy quality of life (18 citations) highlighted the critical role of individual surgical technique in patient recovery. Through studies on technology diffusion and salvage prostatectomy, Strope has consistently illuminated how market forces and technical advances shape treatment decisions, making him a key voice in the ongoing debate over value and outcomes in urologic oncology.